GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » EV-to-FCF

Accustem Sciences (Accustem Sciences) EV-to-FCF : -2.26 (As of May. 25, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Accustem Sciences's Enterprise Value is $3.18 Mil. Accustem Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.41 Mil. Therefore, Accustem Sciences's EV-to-FCF for today is -2.26.

The historical rank and industry rank for Accustem Sciences's EV-to-FCF or its related term are showing as below:

ACUT' s EV-to-FCF Range Over the Past 10 Years
Min: -4.21   Med: 0   Max: 0
Current: -2.26

ACUT's EV-to-FCF is ranked worse than
100% of 372 companies
in the Biotechnology industry
Industry Median: 8.36 vs ACUT: -2.26

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Accustem Sciences's stock price is $0.277. Accustem Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.150. Therefore, Accustem Sciences's PE Ratio for today is At Loss.


Accustem Sciences EV-to-FCF Historical Data

The historical data trend for Accustem Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences EV-to-FCF Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
EV-to-FCF
-8.09 -4.41

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only -4.24 -7.54 -5.18 -4.41 -2.82

Competitive Comparison of Accustem Sciences's EV-to-FCF

For the Biotechnology subindustry, Accustem Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accustem Sciences's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Accustem Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Accustem Sciences's EV-to-FCF falls into.



Accustem Sciences EV-to-FCF Calculation

Accustem Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3.177/-1.407
=-2.26

Accustem Sciences's current Enterprise Value is $3.18 Mil.
Accustem Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accustem Sciences  (OTCPK:ACUT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Accustem Sciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.277/-0.150
=At Loss

Accustem Sciences's share price for today is $0.277.
Accustem Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.150.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Accustem Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Accustem Sciences (Accustem Sciences) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.